Syenex

Syenex, a NU startup and InQbation Lab resident, is competing in the Biotools Innovator Video Competition and they need your support! This year's Biotools Innovator cohort features 20 life science tools and diagnostics companies dedicated to revolutionizing the biotech landscape. The winning company will receive a $10k prize so be sure to "like" their video by September 18th! Let's come together and show some love for #Syenex! #biotech #genedelivery #lifescience #cellandgenetherapy #winners ??

Syenex is democratizing access to advanced cell & gene therapy biotechnologies. Watch their pitch video & like it on YouTube to vote for them to win the $10K #BTIBestVideo https://lnkd.in/gD4rQs6U Join Syenex at the Capstone event in Boston on 9/26: https://hubs.ly/Q02NC6ns0. Jay Rosanelli

*Please "like" our video on YouTube* to support Syenex in the Biotools Innovator video competition by September 18. Thanks to Silpol Dhiantravan and David Diouf for making it happen. https://lnkd.in/gek7jqHm

Syenex is revolutionising drug development with innovative shared delivery technologies. We’re excited to unveil their new identity, a result of our fruitful collaboration with Jay Rosanelli and Joshua Leonard. See the full case here: https://lnkd.in/dHSN3rSG #design #visualidentity #lifescience #branding

A flexible design system for Syenex, creating a strong brand identity for implementations large and small. See the full case?here: https://lnkd.in/dHSN3rSG #design #brandidentity #lifescience

*Please "like" our video on YouTube* to support Syenex in the Biotools Innovator video competition by September 18. Thanks to Silpol Dhiantravan and David Diouf for making it happen. https://lnkd.in/gek7jqHm

Congratulations Umoja Biopharma! Engineering T cells in vivo has the potential to 100x the reach of CAR T-cell therapies. Best of luck on the study.

Very excited to share two new publications focused on bioengineering of extracellular vesicles! Both out now!

Delivery vehicles and programmable payloads are critical components for all advanced therapies and are independent of a drug developer's core therapeutic insights. We provide best-in-class versions of these components to advanced therapy drug developers to accelerate the creation of new cures

We are excited to join the BioTools Innovator 2024 cohort! Looking forward to collaborating with other innovators building companies to accelerate the development of new medicines.